Atlas Trials

Piperacillin-Tazobactam Continuous Versus Intermittent Infusion for Pseudomonas Aeruginosa

Clinical trial NCT01577368 · COMPLETED

Trial details

NCT number
NCT01577368
Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Pseudomonas Aeruginosa Infection
Start date
2011-05-01
Primary completion
2014-01-01
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.